OTCM
AVTXF
Market cap142mUSD
Oct 19, Last price
5.64USD
1Q
-29.39%
IPO
25.37%
Name
Avantium NV
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Avantium N.V., a chemical technology firm based in the Netherlands, is dedicated to innovating and commercializing sustainable chemistry solutions. The company's operations are divided into three core segments: Avantium Catalysis, Avantium Renewable Chemistries, and Avantium Renewable Polymers. It manufactures furandicarboxylic acid (FDCA), a key ingredient for polyethylene furanoate (PEF), as well as PEF itself, a plant-derived, recyclable plastic suitable for packaging. Avantium also offers catalyst testing systems, including the Flowrence platform for evaluating catalysts and adsorbents. Its services extend to providing R&D systems, various support services, and refinery catalyst testing. Moreover, the company is developing "Ray" technology to produce mono-ethylene glycol (MEG) from industrial sugars and "Dawn" technology, which converts non-food plant biomass into industrial sugars and lignin. Additionally, Avantium produces polyesters using plantMEG. The company was founded in 2000 and has its headquarters in Amsterdam, the Netherlands.
Key people
A.M. Boersma
Chairman of the Supervisory Board · since 2017
Frank C.H. Roerink
Chief Financial Officer, Member of the Management Board · since 2007
S. Olivier
Managing Director of Catalysis · since 2015
Gert-Jan M. Gruter
Chief Technology Officer · since 2004
Carmen Helena Portocarero
Legal Counsel · since 2012
Tom B. van Aken
Chief Executive Officer, Member of the Management Board · since 2006
Jan van der Eijk
Vice Chairman of the Supervisory Board
D.J. Lucquin
Member of the Supervisory Board · since 2011
G.E.A. Reijnen
Member of the Supervisory Board · since 2015
C.J. Stoufs
Member of the Supervisory Board · since 2008
J.S. Wolfson
Member of the Supervisory Board · since 2013
Headquarters & legal address
Zekeringstraat 29
Amsterdam 1014BV
NL
Amsterdam 1014BV
NL
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||